# Tempest Therapeutics, Inc.: Form SCHEDULE 13D/A, filed Mar 25, 2026

- Company: [Tempest Therapeutics, Inc.](/companies/tpst.md) (CIK 1544227)
- Form: SCHEDULE 13D/A
- Filed: 2026-03-25
- Accepted by EDGAR: Mar 25, 2026, 17:33 ET
- Period: not reported
- Accession: 0001931356-26-000013
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1544227/000193135626000013/xslSCHEDULE_13D_X02/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1544227/000193135626000013/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1544227/000193135626000013/xslSCHEDULE_13D_X02/primary_doc.xml

Filed Mar 25, 2026.
Source: SEC EDGAR, the filing index for accession 0001931356-26-000013. Last ingested by Listed: Nov 15, 2026, 00:20 ET. No prices; not investment advice.
